Skip to main content

Author: Editorial Team

The editorial team from Sphingotec is researching the latest scientific updates and combines it with diagnostic insights from the frontlines.

Liberation from Renal Replacement Therapy in Acute Kidney Injury patients: The current routine and insights into the future

The decision to stop RRT is a critical step that necessitates careful consideration of various clinical parameters. Currently, the liberation rocess is informed by changes in traditional kidney function markers, such as serum creatinine and urine output, in conjunction with the patient's clinical status.

Current applications of precision medicine in intensive care medicine

Patients suffering from one particular disease are often treated with the same drug – independent of their age, gender, origin, or even the underlying disease mechanisms, which can vary greatly among different patients. In the field of personalized medicine, these differences are considered with the aim of providing individualized treatment to help the patient with the best possible outcome.

Could it be Sepsis?

„Could it be sepsis? The DeutschlandErkenntSepsis campaign highlights the importance of knowing the signs and symptoms of sepsis to reduce preventable deaths from sepsis and improve outcomes for survivors. Read more in our blog post.

The Era of AKI Biomarkers

Acute kidney injury (AKI) is featured by acute deterioration in renal function, defined by changes in serum creatinine (SCr), urine output, or both. As one syndrome, AKI encompasses a wide variety of causes and risk factors, leading to a decline in kidney function or renal damage.